Junior Service League presents annual Viva El Vino Event Saturday night kjct8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kjct8.com Daily Mail and Mail on Sunday newspapers.
Provided by GlobeNewswire
Developer of World’s First Industrial Centrifugal Partition Chromatography Platform Extends Leadership Team
Budapest, Hungary, Feb. 23, 2021 (GLOBE NEWSWIRE) via NewMediaWire RotaChrom Technologies (“RotaChrom” or the “Company”), the developer of the world s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the promotion of Andras Gaspar, Ph.D., to Chief Product Officer.
In his new role, Andras will oversee all product development and engineering processes at RotaChrom, where his intimate knowledge of chemistry and engineering required to run the Company’s chromatography product lines will be put to use. The products and services that RotaChrom provides are of the highest quality and at the forefront of purification technology, and Andras will continue to ensure this level of quality for all RotaChrom customers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment
RotaChrom TechnologiesFebruary 8, 2021 GMT
New Partnership Aims to Develop More Efficient, Cost-Effective Process to Purify Remdesivir
Budapest, Hungary, Feb. 08, 2021 (GLOBE NEWSWIRE) via NewMediaWire RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of a collaboration with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. (“Cyclolab″), a cyclodextrin research, development and manufacturing company. This strategic partnership between Cyclolab and RotaChrom aims to develop a more efficient and cost-effective process to purify Remdesivir, which is a widely used treatment option for COVID-19.